NCT05959642 is a NA clinical trial of dentapen in Early Childhood Caries, sponsored by Cairo University.

Who is sponsoring NCT05959642?

NCT05959642 is sponsored by Cairo University.

What drugs are being tested in NCT05959642?

Interventions in NCT05959642: dentapen, Traditional metal Syringes.

What condition does NCT05959642 study?

NCT05959642 studies Early Childhood Caries.

Is NCT05959642 still recruiting?

NCT05959642 is currently status unknown. Last updated 27 July 2023.

Last reviewed 2023-07-27 · How we verify

NCT05959642

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparing Controlled Flow Delivery Dentapen® Technique to Traditional Syringes

Status unknown NA Last updated 27 July 2023

What this trial tests

NA trial testing dentapen in Early Childhood Caries in 20 participants. Status unknown.

Timeline

1 January 2024

Primary endpoint
30 October 2024

1 December 2024

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	20
Start date	1 January 2024
Primary completion	30 October 2024
Estimated completion	1 December 2024

Drugs / interventions tested

dentapen
Traditional metal Syringes

Conditions studied

Early Childhood Caries — all drugs for Early Childhood Caries →

Sponsor

Cairo University

Who can join

Adults 6 to 8, any sex, with Early Childhood Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares the effect of the controlled flow delivery Dentapen® technique to traditional syringes on pain perception during dental procedures among a group of pediatric dental patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Early Childhood Caries

Currently open trials in the same condition.

NCT05761197 — Oropharyngeal Candidiasis (OPC) and S-ECC · recruiting
NCT06441500 — Oral Health and Dental Caries Prevention Intervention for Children in Romania · NA · recruiting
NCT06241261 — Arresting Early Childhood Caries With a Silver Diamine Fluoride Gel · Phase 2 · active not recruiting
NCT05716867 — Salivary Cystatin S Levels in a Group of Egyptian Children · active not recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05959642 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 27 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05959642.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing